Company profile

Incorporated in
Fiscal year end

PFE stock data



9 May 19
18 Jun 19
31 Dec 19


Company financial data Financial data

Quarter (USD) Mar 19 Dec 18 Sep 18 Jul 18
Revenue 13.12B 13.98B 13.3B 13.47B
Net income 3.88B -393M 4.11B 3.87B
Diluted EPS 0.68 -0.05 0.69 0.65
Net profit margin 29.61% -2.81% 30.94% 28.75%
Operating income* 4.68B -588M 4.48B 4.85B
Net change in cash 798M -2.42B 855M 402M
Cash on hand 1.94B 1.14B 3.56B 2.7B
Cost of revenue 2.43B 3.08B 2.69B 2.92B
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 53.65B 52.55B 52.82B
Net income 11.15B 21.31B 7.22B 6.96B
Diluted EPS 1.87 3.52 1.17 1.11
Net profit margin 20.79% 40.55% 13.66%
Operating income* 13.17B 13.53B 9.51B 10.14B
Net change in cash -203M -1.25B -1.05B 298M
Cash on hand 1.14B 1.34B 2.6B 3.64B
Cost of revenue 11.25B 11.23B 12.32B 9.65B

Financial data from Pfizer earnings reports. *Asterisk values are approximate.

Financial report summary

Management Discussion
  • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  • See the Glossary of Defined Terms at the beginning of this Quarterly Report on Form 10-Q for terms used throughout this MD&A. Our MD&A is provided in addition to the accompanying condensed consolidated financial statements and footnotes to assist readers in understanding Pfizer’s results of operations, financial condition and cash flows. The MD&A is organized as follows:
  • Certain amounts in our MD&A may not add due to rounding. All percentages have been calculated using unrounded amounts.
Content analysis ?
8th grade Avg
New words: accommodate, achondroplasia, adalimumab, Advair, advocacy, Ajanta, alopecia, altering, areata, arm, automate, automation, awaited, azacitidine, Azar, bacteria, Bamboo, began, beta, bioequivalence, bioequivalent, Biopharma, British, cervix, cGMP, Chennai, cohesive, colon, composition, confluence, Congressional, conjugate, costly, counter, coupled, criterion, Cyanamid, deconsolidate, destocking, digestive, digital, draft, dramatic, dramatically, dwarfism, element, emphasized, explicitly, export, fee, fleet, fluticasone, forestalling, Fragmin, framework, frontline, furnished, gBRCA, genetic, Genotropin, globe, Goldman, GSK, harbor, hard, harm, hereditary, hindsight, history, Idec, IKKT, immunotherapy, implicit, Imputed, inception, India, inhalation, Inhub, Irungattukottai, JAVELIN, LA, lactamase, leader, MBC, mCRPC, Medrol, mineral, modest, moved, moving, municipal, mutual, myriad, nmCRPC, nonrecurring, notification, OAI, outweigh, Parliament, path, paused, payor, penalty, persistent, Pharmacology, physician, pilot, powder, preclude, premarket, propionate, prosecution, provincial, Proxy, QCE, RA, realigning, reallocated, Rebif, rectum, refine, refuse, renamed, rent, Residual, retirement, Rheumatology, ROU, safe, salmeterol, SBS, seize, show, side, signal, simplification, skin, solicited, solid, sooner, strictly, sublease, suboptimal, Supreme, susceptibility, tendering, Therachon, TKI, Tygacil, UC, unclear, unconstitutional, unselected, Urbanization, vast, Vietnam, vii, vitamin, Vyndaqel, White, Wixela, WRDM, Xyntha, Zithromax
Removed: acceptable, acceptance, accessible, accreted, accrual, accurate, added, adequately, adjunct, adjuvant, Advil, aggregating, Amerigen, Amsterdam, assertion, assurance, ASU, attained, attempt, authoritative, Avillion, banking, behavior, beneficiary, Besponsa, BLA, bond, borrowed, Bosulif, bowel, broader, Bulletin, buyer, capitalized, CD, ceftaroline, ceiling, Centrum, Chemistry, clarification, CML, collaborated, collateralized, collected, Commencing, commercialize, commercializing, commercially, complexity, concentrated, consolidate, corroborated, counterbalance, Crohn, curtailment, customer, CXL, damage, Darmstadt, deciding, default, denied, Derecognition, designating, designation, designing, destroyed, determinable, diagnosed, diagnostic, diet, dietary, disaggregation, disposition, diversified, diversion, doublet, doughnut, duration, efficiency, eliminated, embedded, ending, enrollment, essentially, Euromonitor, exclusive, exclusively, expanded, expectancy, extension, extinguishment, extract, facilitate, fell, fesoterodine, finalize, forward, fosamil, free, freeze, froze, frozen, gastrointestinal, genuine, glycaemic, glycemic, grand, granting, Guaranty, hierarchy, highlighted, hole, Honjo, hospitalized, identical, identified, imposing, impracticable, inappropriate, incurring, inflammatory, initially, innovating, inoperability, inoperable, inside, Inspra, institute, instrument, interpretation, interval, intolerance, invoiced, Israel, issuer, Januvia, joined, jury, kidney, lack, lag, lapse, Leading, legislated, lessee, lessor, lifting, liquidation, loan, London, lorlatinib, low, lymphoblastic, maintained, marketability, maximally, Medication, meropenem, metformin, Mexico, missing, month, movement, mutation, Mylotarg, narrowed, nephrectomy, Nivestim, nonfinancial, NovaQuest, novo, observable, offer, offsetting, Ono, operationally, opposite, orderly, original, passage, patented, performing, persuasive, Ph, Philadelphia, pool, practicable, precursor, preliminary, prepayment, prescriber, priority, produced, prohibition, prolonging, promissory, promyelocytic, proper, proportion, provisional, psoriatic, publication, ratably, ratio, reaching, readily, reclassifying, refractory, refunded, regimen, relapsed, relocating, remitted, repaid, representation, requesting, residential, restriction, resumed, Retacrit, retail, returned, Revatio, reverse, RPI, Russia, secured, Segluromet, selectively, seller, sensitivity, sham, shelf, shipment, shipped, shorter, sitagliptin, splitting, spot, Squibb, stable, Steglatro, Steglujan, stranded, StratCO, strike, strove, student, SU, suggested, sulphonylurea, summarized, supported, surgical, swap, Tasuku, temporary, title, titled, tolerated, tool, Topic, Torrent, Toviaz, Track, Trading, transfer, transitional, UCB, unbudgeted, undertaken, underway, unlimited, unpatented, untreated, upholding, vendor, watch, whichever, withdrew, WRD, Zavicefta, zeta, Zinforo